Related Experiment Video
Updated: Jan 14, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Combined P-Value Functions for Compatible Effect Estimation and Hypothesis Testing in Drug Regulation.
Samuel Pawel1, Małgorzata Roos1, Leonhard Held1
1Epidemiology, Biostatistics and Prevention Institute (EBPI), Center for Reproducible Science (CRS), University of Zurich, Zurich, Switzerland.
Drug regulation
Area of Science:
- Biostatistics
- Pharmacometrics
- Regulatory Science
Background:
- The two-trials rule in drug efficacy requires two significant trials.
- Combining effect estimates from multiple trials is complex.
- Fixed-effect meta-analysis may produce misleading confidence intervals.
Purpose of the Study:
- To unify the two-trials rule and meta-analysis within a combined p-value framework.
- To derive compatible p-values, effect estimates, and confidence intervals.
- To evaluate different p-value combination methods for two trials.
Main Methods:
- Recasting the two-trials rule and meta-analysis using combined p-value functions.
- Deriving closed-form solutions for p-values, effect estimates, and confidence intervals.
- Analyzing Wilkinson's, Stouffer's, Edgington's, Fisher's, Pearson's, and Tippett's methods.
Main Results:
- All methods consistently estimate the true effect when trials have identical effects, though bias varies.
- Methods differ in their convergence when true effects diverge: conservative (Pearson's), anti-conservative (Fisher's, Tippett's), and balanced (Edgington's, meta-analysis).
- Edgington's confidence intervals encompass individual trial effects, unlike meta-analytic intervals.
Conclusions:
- The choice of method depends on the specific estimand of interest.
- All analyzed methods can be appropriate for combining results from two trials.
- The R package 'twotrials' facilitates compatible hypothesis testing and effect estimation.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Bioequivalence Data: Statistical Interpretation
Statistical Hypothesis Testing
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Dose-Response Relationship: Potency and Efficacy